Sivils Kathy L - Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 185 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Variants in the DDX6-CXCR5 Autoimmune Disease Risk Locus Influence the Regulatory Network in Immune Cells and Salivary Gland

Mandi M Wiley, Marcin Radziszewski,Bhuwan Khatri,Michelle L Joachims, Kandice L Tessneer, Anna M Stolarczyk, Songyuan Yao, James Li, Cherilyn Pritchett-Frazee, Audrey A Johnston,Astrid Rasmussen,Juan-Manuel Anaya,Lara A Aqrawi,Sang-Cheol Bae,Eva Baecklund,Albin Björk,Johan G Brun, Sara Magnusson Bucher,Nick Dand,Maija-Leena Eloranta, Fiona Engelke,Helena Forsblad-d'Elia, Cecilia Fugmann,Stuart B Glenn, Chen Gong,Jacques-Eric Gottenberg,Daniel Hammenfors,Juliana Imgenberg-Kreuz,Janicke Liaaen Jensen, Svein Joar Auglænd Johnsen,Malin V Jonsson, Jennifer A Kelly,Sharmily Khanam,Kwangwoo Kim,Marika Kvarnström,Thomas Mandl,Javier Martín, David L Morris,Gaetane Nocturne,Katrine Brække Norheim,Peter Olsson,Øyvind Palm,Jacques-Olivier Pers, Nelson L Rhodus,Christopher Sjöwall,Kathrine Skarstein,Kimberly E Taylor, Phil Tombleson,Gudny Ella Thorlacius, Swamy R Venuturupalli,Edward M Vital, Daniel J Wallace,Lida Radfar,Michael T Brennan,Judith A James, R Hal Scofield,Patrick M Gaffney,Lindsey A Criswell,Roland Jonsson,Silke Appel,Per Eriksson, Simon J Bowman,Roald Omdal,Lars Rönnblom,Blake M Warner,Maureen Rischmueller,Torsten Witte,A Darise Farris,Xavier Mariette, Caroline H Shiboski, Sjögren’s International Collaborative Clinical Alliance (SICCA),Marie Wahren-Herlenius,Marta E Alarcón-Riquelme, PRECISESADS Clinical Consortium, Wan-Fai Ng, UK Primary Sjögren’s Syndrome Registry,Kathy L Sivils, Joel M Guthridge,Indra Adrianto, Timothy J Vyse, Betty P Tsao,Gunnel Nordmark, Christopher J Lessard

Annals of the rheumatic diseases (2025)

Cited0Views0WOSBibtex

A Cross-Sectional Observational Study of Patients with Sicca with Salivary Autoantibodies Defines a Potential New Phenotype of Sjögren's Disease

Martha Tsaliki, Joshua Cavett,Biji T Kurien, Christina Bruxvoort, Valerie M Lewis, John A Ice, Devavrat Dave, Sina Khosravani,Kiely Grundahl, Christopher J Lessard,Astrid Rasmussen,Kathy L Sivils, Amy Darise Farris,Kristi A Koelsch, Robert Hal Scofield

Annals of the rheumatic diseases (2025)

Cited0Views0WOSBibtex

LBA0010 EFFICACY AND SAFETY OF NIPOCALIMAB, AN ANTI-FcRn MONOCLONAL ANTIBODY, IN PRIMARY SJOGREN’S DISEASE: RESULTS FROM A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY (DAHLIAS)

Gottenberg J.E.,Sivils K.,Campbell K., Idokogi J., Lo K.H., Liva S., Dhatt H., Hubbard J., Noaiseh G.

Annals of the Rheumatic Diseases (2024): 240

Cited0Views0Bibtex

Observed and Simulated Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Fully Human FcRn Blocking Monoclonal Antibody, in Adults with Sjogren's Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study

Sophia G. Liva, Fudan Zheng,Jocelyn H. Leu,Kathy Sivils,Keying Ma,He Li, Steven Leonardo,Kim Lo, Jada Idokogi,Kim Campbell, Jonathan J. Hubbard

ARTHRITIS & RHEUMATOLOGY (2024): 2896-2897

Cited0Views0Bibtex

AB0809 USER-FRIENDLY TOOL FOR EXPLORING RNA-SEQUENCE AND BIOMARKER DISCOVERY IN SJOGREN’S DISEASE: ANALYSE THE TWO BIGGEST DATASETS OF BLOOD AND SALIVARY GLAND RNA-SEQUENCING DATA USING R SHINY APPS

Pontarini E.,Sciacca E., Cavallaro G.,Galbraith D.,Pulvirenti A., Hao L.Y.,Sivils K.,Lewis M.,Pitzalis C.,Bombardieri M.

Annals of the Rheumatic Diseases (2024): 1699

Cited0Views0Bibtex

Pharmacodynamic Effects of Nipocalimab on Disease Biomarkers in Patients with Moderate-to-Severe Active Sjogren's Disease: Results from a Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2 Study

Kathy Sivils, Steven Leonardo,He Li,Keying Ma,Matthew J. Loza, Jonathan J. Hubbard,Kim Campbell,Sheng Gao

ARTHRITIS & RHEUMATOLOGY (2024): 4616-4618

Cited0Views0Bibtex

Efficacy and Safety of Nipocalimab, an Anti-FcRn Monoclonal Antibody, in Primary Sjogren's Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (DAHLIAS)

Jacques-Eric Gottenberg,Kathy Sivils,Kim Campbell, Jada Idokogi,Kim Lo,Sophia G. Liva, Jonathan Shelton, Harman Dhatt, Jonathan J. Hubbard,Ghaith Noaiseh

ARTHRITIS & RHEUMATOLOGY (2024): 5140-5141

Cited0Views0Bibtex

Sjogren's Disease and Non-Sjogren's Sicca Patient Subsets Exhibit Cell Type-specific Transcriptional Dysregulations That May Identify Early Molecular Predictors of Disease Transition

James Li,Chuang Li,Bhuwan Khatri,Anna Stolarczyk,Kandice Tessneer,Astrid Rasmussen,Joel Guthridge,Judith James,Robert Hal Scofield,He Li,A. Darise Farris,Kathy Sivils,Christopher Lessard

ARTHRITIS & RHEUMATOLOGY (2024): 5159-5161

Cited0Views0Bibtex

Mitochondrial Dysfunction and Fatigue in Sjögren's Disease

Biji T. Kurien, Rebecca Wood,Gavin Pharaoh,Joshua Cavett,Valerie Lewis,Bhaskaran Shylesh,Lida Radfar,Astrid Rasmussen,Christopher Lessard,A. Darise Farris,Kathy Sivils,Kristi Koelsch,Holly Van Remmen,R. Hal Scofield

ARTHRITIS & RHEUMATOLOGY（2023）

Cited0Views0WOSBibtex

POS1130 DESIGNING OF A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN INHIBITOR, IN ADULTS WITH PRIMARY SJÖGREN’S SYNDROME

J. Hubbard,K. Campbell,K. Sivils,R. Hoffman, K.H. Lo,J.H. Leu,S. Bowman, S. Liva,Q. Zuraw,A.M. Stevens,L. Ling,K. Karcher,S. Ramchandren, H. Sun,R.H. Scofield,R. Seror,D.J. Wallace

Annals of the Rheumatic Diseases (2023): 892-893

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn